Earnings NewsHealthcareKite Pharma Q2 resultsAug. 14, 2014 6:20 PM ETKite Pharma (KITE) StockBy: Douglas W. House, SA News Editor Kite Pharma (NASDAQ:KITE -3.8%) Q2 results: Revenues: $0; Operating Expenses: $11.1M (+677.4%); Net Loss: ($17.4M) (-999%); Loss Per Share: ($2.27) (-609.4%); Quick Assets: $203.4M (+808.0%). No financial guidance given. Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgKITE--Kite PharmaTrending AnalysisTrending News